Cargando…

Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men

BACKGROUND: Several clinical trials and meta-analyses have shown the advantageous effects of statins in populations with different levels of cardiovascular disease (CVD) risk. Considering the increasing cardiovascular risk among the Iranian population, the cost-effectiveness of the use of simvastati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amirsadri, Mohammadreza, Hassani, Abbas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697320/ https://www.ncbi.nlm.nih.gov/pubmed/26717884 http://dx.doi.org/10.1186/s40199-015-0129-2

Ejemplares similares

154: A PHARMACOECONOMIC EVALUATION TO MAKE DECISION: IS THE USE OF SIMVASTATIN 10 MG AS AN OTC MEDICATION COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF STROKE AMONGST WOMEN IN IRAN?
por: Amirsadri, Mohammadreza, et al.
Publicado: (2017)

Cost-Effectiveness and Cost–Utility Analysis of the Use of Clopidogrel and Pantoprazole in Comparison with Clopidogrel and Omeprazole for the Secondary Prevention of Myocardial Infarction in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2021)

Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2017)

Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2023)

Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2019)

Temporal trends in healthcare resource utilization and costs following acute myocardial infarction
por: Shiyovich, Arthur, et al.
Publicado: (2020)

Costs and benefits of treatment of myocardial infarction
por: Simoons, M. L.
Publicado: (2013)

Cost-effectiveness of surgical excision versus Mohs micrographic surgery for nonmelanoma skin cancer: A retrospective cohort study
por: Nassiripour, Leila, et al.
Publicado: (2016)

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial
por: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group
Publicado: (2010)

Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke
por: Wald, Nicholas J., et al.
Publicado: (2016)

The Medical Unit of the O.T.C.
Publicado: (1910)

Cardiorenal Safety of OTC Analgesics
por: White, William B., et al.
Publicado: (2018)

Bréve: Chloroquine OTC : danger !
por: Dalmat, Yann-Mickael
Publicado: (2020)

Bréve : Chloroquine OTC : danger !
por: Dalmat, Yann-Mickael
Publicado: (2020)

Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
por: Viigimaa, Margus, et al.
Publicado: (2010)

Where to buy OTC medications? A cross-sectional survey investigating consumers’ confidence in over-the-counter (OTC) skills and their attitudes towards the availability of OTC painkillers
por: Brabers, A E M, et al.
Publicado: (2013)

Cost-effectiveness Analysis of Cetuximab in Treatment of Metastatic Colorectal Cancer in Iranian Pharmaceutical Market
por: Davari, Majid, et al.
Publicado: (2015)

A 30-Month Evaluation of the Effects on the Cost and Utilization of Proton Pump Inhibitors From Adding Omeprazole OTC to Drug Benefit Coverage in a State Employee Health Plan
por: West, Donna S., et al.
Publicado: (2006)

Review of Cost-Effectiveness Analysis of Medical Treatment For Myocardial Infarction
por: Liu, Yanmei, et al.
Publicado: (2011)

Epidemiology and Management Cost of Myocardial Infarction in North Punjab, Pakistan
por: Iqbal, Riffat, et al.
Publicado: (2015)

The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada
por: Tran, Dat T., et al.
Publicado: (2017)

Use of OTC-drugs prior to Hospitalization
por: Pedersen, Magnus, et al.
Publicado: (2013)

Marketing approaches for OTC analgesics in Bulgaria
por: Petkova, Valentina, et al.
Publicado: (2014)

The Box—eHealth in the Outpatient Clinic Follow-up of Patients With Acute Myocardial Infarction: Cost-Utility Analysis
por: Treskes, Roderick Willem, et al.
Publicado: (2022)

Exercise in preventing falls for men with prostate cancer: a modelled cost-utility analysis
por: Edmunds, Kim, et al.
Publicado: (2022)

The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction
por: Schreyögg, Jonas, et al.
Publicado: (2010)

Short term cost effectiveness of a regional myocardial infarction network
por: Birkemeyer, Ralf, et al.
Publicado: (2013)

Spatial analysis of myocardial infarction in Iran: National report from the Iranian myocardial infarction registry
por: Ahmadi, Ali, et al.
Publicado: (2015)

OTC analgesics and drug interactions: clinical implications
por: Fendrick, A Mark, et al.
Publicado: (2008)

SAT-497 Importance of OTC Medications in Hypercalcemia
por: Yedla, Niharika, et al.
Publicado: (2019)

OTC product: Kleenex Anti-Viral tissue
por: Spencer, Beth P.
Publicado: (2008)

Consumer Impressions of the Safety and Effectiveness of OTC Medicines
por: Taylor, Jeffrey Gordon, et al.
Publicado: (2023)

Consumer Likelihood to Seek Information on OTC Medicines
por: Taylor, Jeffrey G., et al.
Publicado: (2023)

Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
por: Liang, Zhe, et al.
Publicado: (2021)

The role of the ERK1/2 pathway in simvastatin-loaded nanomicelles and simvastatin in regulating the osteogenic effect in MG63 cells
por: Niu, Mao, et al.
Publicado: (2018)

Determinants of Hospital Inpatient Costs in the Iranian Elderly: A Micro-costing Analysis
por: Hazrati, Ebrahim, et al.
Publicado: (2020)

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
por: Mihaylova, Borislava, et al.
Publicado: (2016)

Medical costs of osteoporosis in the Iranian elderly patients
por: Alipour, Vahid, et al.
Publicado: (2020)

Effects of medical insurance system on the hospitalization cost of acute myocardial infarction patients
por: Chu, Ying-Hong, et al.
Publicado: (2022)

Efficacy of Ezetimibe/Simvastatin (10/10 mg) versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials
por: YANG, Gaoming, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ioit20ql6mfrvjs9rol66c55vj